ERCC2 and non-Hodgkin lymphoma: In a meta-analysis of 3095 patients with NHL and 3306 controls conducted on a Caucasian, Asian, and mixed ethnicities population, no significant association between XPD 2251A>C polymorphism and the risk of Hodgkin’s lymphoma was brought to light [30].